Nolsøe, Alexander Bjørneboe
Holm, Henriette Veiby
Murtola, Teemu J.
Østergren, Peter Busch http://orcid.org/0000-0003-4762-039X
Fode, Mikkel
Article History
Received: 14 July 2023
Revised: 25 September 2023
Accepted: 26 September 2023
First Online: 10 October 2023
Competing interests
: Alexander Bjørneboe Nolsøe: None, Henriette Veiby Holm: Speaker’s fees from Boston Scientific, Teemu J. Murtola: Speaker’s fees from Ferring, Novartis, Janssen, Sanofi, Bayer, Roche, Pfizer, Ipsen, Astellas, Amgen, Consulting fees from Novartis, Astellas Pharma, Janssen, Amgen and Recordati. Clinical trial funding from Bayer, Orion, Janssen and Pfizer, Peter Busch Østergren: Speaker’s fees from Ipsen, Astellas Pharma, and Ferring Pharmaceuticals, Mikkel Fode: Speaker’s fees from Astellas Pharma and Boston Scientific.